Insulin (Novo Nordisk)

N/A

Report date: 2023/11/17 15:34:12

Base Information

Drug NameInsulin (Novo Nordisk)
Drug Alias NameInsulin-965Insulin 965FSI 965NNC-965NNC0268 0965
ClassificationBiologics > Protein drugs
Mechanisms of ActionInsulin receptor agonistsOrnithine decarboxylase stimulantsPhosphokinases stimulants +[4] 
TargetsInsulin receptorOrnithine decarboxylasePhosphokinases +[4] 
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusDiscontinued
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A